CASE DISCUSSION
Non surgical therapies for valve repairs and replacements
Presented from India by Dr. B. V. A. RangareddyViews
5,258
0
Credit Points
0
Learning Hours
0
CPD/CME Points
0
Courses Completed
Case Description
Non-surgical therapies for valve repairs and replacements offer alternative options to traditional open-heart surgery for patients with heart valve disorders. TAVR is a minimally invasive procedure that involves replacing a narrowed aortic valve with a bioprosthetic valve via a catheter. It's often...
Case Summary
- The discussion centered on non-surgical, percutaneous interventions for structural heart disease, particularly focusing on valve repair and replacement. Traditionally, open-heart surgery with large incisions and heart stoppage was the norm, but newer techniques offer alternatives for high-risk patients or those unsuitable for open surgery. The conversation highlighted the limitations of medications in treating structural valve modifications.
Speaker Profile
Dr. B. V. A. Rangareddy
Alumni- Sri Ramachandra UniversityConsultant Interventional Cardiologist, Apollo Hospitals, Hyderabad
Dr. Ranga Reddy, MBBS, MD (General Medicine), DM (Cardiology)
Consultant Interventional Cardiologist, Apollo Hospitals, Jubilee Hills, Hyderabad
Dr. Ranga Reddy completed his MBBS from Christian Medical College, Vellore, followed by MD in General Medicine from Mahatma Gandhi Medical College, Pondicherry, and DM in Cardiology from Sri Ramachandra Medical College, Chennai. He is currently working as a Consultant Interventional Cardiologist at Apollo Hospitals, Jubilee Hills, Hyderabad.
With extensive teaching experience, Dr. Reddy has been involved in teaching Internal Medicine and Cardiology at Mahatma Gandhi Medical College, Pondicherry, and has been teaching Cardiology to DNB candidates since 2017. He has published several papers in various international journals and has a deep expertise in performing complex angioplasties, including Left Main, TVDs, Bifurcations, CTOs, and Primary Angioplasty.
Dr. Reddy has a special interest in Carotid, Peripheral, Endovascular, and Structural Interventions.
Disclosures
Assimilate requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All relevant financial relationships for anyone with the ability to control the content of this educational activity have been reviewed and mitigated. Others involved in the planning of this activity have no relevant financial relationships.